Illumina: insiders and institutional investors adjust ownership stakes
Illumina, Inc. saw significant stock transactions by company leadership and institutional investors this week. Director Keith A. Meister sold 280,091 shares, Corvex Management LP filed a notice of a proposed sale of 375,000 shares, and Capital World Investors reported a 6.7% stake.
Key points
- Director Keith A. Meister executed 21 transactions to sell shares between November 9 and November 11, 2026.
- Capital World Investors holds 10,050,907 shares, representing a 6.7% stake, according to a November 13, 2026, filing.
- The notice of a proposed sale filed by Corvex Management LP is merely a declaration of intent.
Insider and shareholder stock transactions
Director Keith A. Meister executed 21 transactions to sell shares between November 9 and November 11, 2026. He sold a total of 280,091 shares at a weighted average price of $218.1185.
Corvex Management LP, an affiliate of one of the directors, filed a notice of a proposed sale of 375,000 shares. The market value of this stake was $82,792,500 at the time of the filing.
Officer Scott D. Ericksen sold 267 shares on November 10, 2026, at $217.76 per share under a Rule 10b5-1 trading plan, a preset selling schedule executives set up in advance.
Value of shares sold, by insider
Ownership changes and other transactions
Capital World Investors holds 10,050,907 shares, representing a 6.7% stake, according to a November 13, 2026, filing.
On November 5, 2026, four officers—Kevin Carl Pegels, Patricia Leckman, Scott D. Ericksen, and Steven Barnard—disposed of 604, 208, 150, and 360 shares, respectively, to cover tax obligations or exercise prices.
Risks and notes
The notice of a proposed sale filed by Corvex Management LP is merely a declaration of intent. It does not guarantee the shares will be sold.
What to watch
Shareholders should monitor future insider transaction reports to confirm if Corvex Management LP completes the planned sale of 375,000 shares.
Original sources
- 4 filing, November 9, 2026
- 4 filing, November 9, 2026
- 4 filing, November 9, 2026
- 4 filing, November 9, 2026
- 144 filing, November 10, 2026
- 4 filing, November 12, 2026
- 4 filing, November 12, 2026
- SCHEDULE 13G/A filing, November 13, 2026
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Illumina
A notification in your browser or on your phone when we publish about Illumina. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
